Full VWF mutation screen (Type 1 & Type 3 VWD)
- Description
- Analysis of the VWF gene by PCR amplification and sequencing of the coding region and splice junctions. Dosage analysis, via MLPA, is available as a second line test where gross deletions/ insertions are suspected.
- Clinical details
- Von Willebrand Disease is the most common hereditary bleeding disorder, typically associated with mucocutaneous bleeding (epitaxis, menorrhagia), easy bruising and bleeding post dental extraction. Type 1 VWD is autosomal dominant, with an estimated frequency of approximately 1:100-1000. It is generally clinically & phenotypically mild, although severe Type 1 VWD is seen and there is sometimes variable penetrance within families. Mutations are heterogeneous and spread throughout the VWF gene. Type 3 VWD is autosomal recessive and results in severe deficiency of plasma VWF. Patients suffer severe bleeding symptoms including hemarthroses, gastrointestinal bleeds and cerebral hemorrhage. Frequency is estimated at 1:500,000 to 1:2,000,000.
- Related condition
- Reference range
n/a
- Units
- n/a
- Synonyms
- VWF Von Willebrand disease Type 1 VWD Type 3 VWD
- Testing site
- Synnovis : Genomics : St Thomas' Hospital
- Laboratory
- Molecular Haemostasis
- Sample type and volume required
- 1 x Edta
- Call in advance
- no
- Storage and transport
- transport at ambient temperature
- Turnaround time
- 12 weeks
- Contacts
Molecular Haemostasis Laboratory at St Thomas’ Hospital
Phone: 020 7188 2798
Haemostasis and Thrombosis
North Wing – 4th floor
St Thomas’ Hospital
Westminster Bridge Road
London SE1 7EH
Laboratory opening times
Monday – Friday 09.00 – 17.00
